Advances in Bevacizumab Therapy for Non-small Cell Lung Cancer with Brain Metastases
Brain metastases are frequently encountered in patients with non-small cell lung cancer (NSCLC) and are a significant cause of morbidity and mortality. Antiangiogenesis therapy plays a major role in the management of brain metastases in lung cancer. Bevacizumab have become the novel method for the t...
Furkejuvvon:
| Váldodahkkit: | , , |
|---|---|
| Materiálatiipa: | Artigo |
| Giella: | Chinês |
| Almmustuhtton: |
Chinese Anti-Cancer Association; Chinese Antituberculosis Association
2016-08-01
|
| Ráidu: | Chinese Journal of Lung Cancer |
| Fáttát: | |
| Liŋkkat: | http://dx.doi.org/10.3779/j.issn.1009-3419.2016.08.05 |
| Fáddágilkorat: |
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!
|